Results 11 to 20 of about 242,737 (263)
Frontiers in Cardiovascular Medicine, 2021 Background: Catheter ablation has become a well-established indication for long-term rhythm control in atrial fibrillation (AF) patients refractory to anti-arrhythmic drugs (AADs).
Andrea Saglietto +4 more
doaj +1 more source
Editorial to “Revitalizing brain perfusion: Unveiling advancements through rhythm control strategies in atrial fibrillation—A systematic review” [PDF]
Journal of ArrhythmiaYoshimori An
doaj +2 more sources
Rhythm Control in AF: Have We Reached the Last Frontier?
European Cardiology Review, 2019 AF is a worldwide epidemic, affecting approximately 33 million people, and its rising prevalence is expected to account for increasing clinical and public health costs.
Gheorghe-Andrei Dan
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2021 Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research center ...
N. Yu. Mironov +18 more
doaj +1 more source
The Challenges of Tachycardia Induced Cardiomyopathy - a Case Report [PDF]
Romanian Journal of Cardiology, 2021 Tachycardia-induced cardiomyopathy (TIC) is characterized by reversible left ventricular dysfunction caused by long-standing tachycardia. Treatment options for tachyarrhythmias causing TIC have evolved, especially the rhythm control strategies, ensuring ...
Andreea Elena VELCEA +2 more
doaj +1 more source
Anatolian Journal of Cardiology, 2020 The co-existence of atrial fibrillation (AF) and acute heart failure (AHF) is frequently reported and can exacerbate either or both of them. Their combination leads to increased morbidity and mortality.
Sercan Okutucu, Bülent Görenek
doaj +1 more source
STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
Российский кардиологический журнал, 2017 Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety
S. G. Kanorsky, Yu. S. Kovalenko
doaj +1 more source
International Journal of Cardiology: Heart & Vasculature, 2021 Background: Sustained new-onset atrial fibrillation (AF) in the intensive care unit has been reported to be associated with poor outcomes. However, in critical illness, whether rhythm-control therapy can achieve sinus rhythm (SR) restoration is unknown ...
Takuo Yoshida +5 more
doaj +1 more source
Chapter 2: Rate Versus Rhythm Control
The American Journal of Cardiology, 2023 Atrial fibrillation (AF) is a potentially serious health risk, both because of its symptoms and because of its association with an increased risk for heart failure, hospitalization, thromboembolism, and death. Chapter 2 discusses selection of appropriate treatments and when to initiate these therapies.
Thomas F, Deering +3 more
openaire +2 more sources
Rhythm control strategy in the transcatheter ablation era [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2021 The latest ESC guidelines on atrial fibrillation limit rhythm control to symptomatic cases, continuing on the same line that the Affirm and Race trials traced twenty years ago.
Riccardo Maddalena
doaj +1 more source